Autolus Therapeutics Ltd Cash Flow-to-Debt Ratio
Autolus Therapeutics Ltd cash flow-to-debt ratio. Autolus Therapeutics Ltd (AUTL) has a Cash Flow-to-Debt Ratio of -0.06x as of June 2026, meaning its operating cash flow of $-25.07 Million could theoretically repay 0% of its total liabilities ($418.39 Million) in one year. See financial flexibility index of Autolus Therapeutics Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Autolus Therapeutics Ltd (2015–2025)
Cash flow-to-debt ratio of Autolus Therapeutics Ltd from 2015 to 2025. Historical debt coverage capacity for Autolus Therapeutics Ltd across 12 annual periods. Also explore Autolus Therapeutics Ltd (AUTL) net asset momentum to track the company's year-over-year net asset growth rate.
Autolus Therapeutics Ltd Cash Flow-to-Debt Ratio by Year (2015–2025)
Autolus Therapeutics Ltd cash flow-to-debt ratio by year from 2015 to 2025. Year-by-year debt coverage analysis for Autolus Therapeutics Ltd. For the full cash flow conversion analysis, see AUTL operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.69x | $-283.57 Million | $410.94 Million | ▼ -18.9% |
| 2024 | -0.58x | $-206.27 Million | $355.40 Million | ▼ -5.2% |
| 2023 | -0.55x | $-145.59 Million | $263.91 Million | ▲ +5.9% |
| 2022 | -0.59x | $-112.31 Million | $191.60 Million | ▲ +54.1% |
| 2021 | -1.28x | $-117.86 Million | $92.24 Million | ▲ +8.6% |
| 2020 | -1.40x | $-117.76 Million | $84.20 Million | ▲ +32.9% |
| 2019 | -2.08x | $-101.48 Million | $48.69 Million | ▼ -0.9% |
| 2018 | -2.06x | $-25.85 Million | $12.52 Million | ▲ +0.0% |
| 2018 | -2.06x | $-25.85 Million | $12.52 Million | ▲ +23.5% |
| 2017 | -2.70x | $-16.36 Million | $6.06 Million | ▲ +4.3% |
| 2016 | -2.82x | $-9.85 Million | $3.49 Million | ▼ -65.2% |
| 2015 | -1.71x | $-3.33 Million | $1.95 Million | — |